Publication | Closed Access

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

Amyloid PeptideAlzheimer's DiseaseIntranasal Nap AdministrationDementiaDegenerative PathologyProtein MisfoldingNeuroscienceTransgenic Mouse ModelNeurodegenerationMedicineCell BiologyLewy Body Dementia